<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2023-3603</article-id><article-id custom-type="edn" pub-id-type="custom">FIPSNA</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-3603</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW ARTICLES</subject></subj-group></article-categories><title-group><article-title>Проблемные вопросы и разработка классификаций основных параметров качества и приверженности фармакотерапии. Часть I: приверженность пациентов к лечению</article-title><trans-title-group xml:lang="en"><trans-title>Problematic issues and development of classifications of the main parameters of quality and adherence to pharmacotherapy. Part I: Patient adherence to treatment</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8252-3099</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукина</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukina</surname><given-names>Yu. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юлия Владимировна Лукина — кандидат медицинских наук, ведущий научный сотрудник лаборатории фармакоэпидемиологических исследований отдела профилактической фармакотерапии.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">yuvlu@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6395-2584</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кутишенко</surname><given-names>Н. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Kutishenko</surname><given-names>N. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Петровна Кутишенко — доктор медицинских наук, руководитель лаборатории фармакоэпидемиологических исследований отдела.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">nkutishenko@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7717-4362</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Марцевич</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Martsevich</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сергей Юрьевич Марцевич — доктор медицинских наук, профессор, руководитель отдела профилактической фармакотерапии.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">sergeymartsevich@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оксана Михайловна Драпкина — доктор медицинских наук, профессор, академик РАН, директор.</p><p>Москва</p></bio><bio xml:lang="en"><p>Moscow</p></bio><email xlink:type="simple">odrapkina@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>20</day><month>07</month><year>2023</year></pub-date><volume>22</volume><issue>6</issue><fpage>3603</fpage><lpage>3603</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лукина Ю.В., Кутишенко Н.П., Марцевич С.Ю., Драпкина О.М., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Лукина Ю.В., Кутишенко Н.П., Марцевич С.Ю., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Lukina Y.V., Kutishenko N.P., Martsevich S.Y., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/3603">https://cardiovascular.elpub.ru/jour/article/view/3603</self-uri><abstract><p>Проблема приверженности пациентов к лечению остается одной из самых актуальных для здравоохранения большинства стран мира. Решению данной проблемы препятствует целый ряд причин: отсутствие единой терминологии, признанного и надежного метода "золотого стандарта" для диагностики приверженности, универсальной стандартизированной тактики повышения показателей приверженности больных к лечению. Несмотря на продолжительную историю исследования и наличие колоссального количества публикаций по теме приверженности терапии, до сих пор отсутствует классификация всех ее изученных на сегодняшний день видов. В связи с этим целью данной обзорно-аналитической работы были сбор информации об идентифицированных к настоящему моменту основных типах приверженности/неприверженности и разработка на основании этих данных классификации приверженности/неприверженности пациентов к лечению. Поиск литературных источников проводился по ключевым словам. В анализ включались публикации за последние 20 лет — 2003-2023гг. В классификацию были отобраны категории приверженности, актуальные с точки зрения общемедицинского подхода к проблеме, оценка которых возможна в условиях реальной клинической практики. Все типы приверженности были сгруппированы по ведущему признаку. Разработанная классификация приверженности/неприверженности пациентов к лечению способна выполнять роль дополнительного инструмента для оценки приверженности, что в дальнейшем может оказаться полезным при выборе тактики и возможных способов повышения приверженности больных к врачебным рекомендациям.</p></abstract><trans-abstract xml:lang="en"><p>The problem of patient adherence to treatment remains one of the most relevant for healthcare in most countries of the world. The solution of this problem is hindered by a number of reasons: no unified terminology, a "gold standard" for adherence assessment, and a universal standardized tactic for improving patient adherence to treatment. Despite the long history of research and a huge number of publications on adherence to therapy, there is still no classification of its types studied to date. In this regard, the purpose of this review and analytical work was to collect information on the main types of adherence/non-adherence identified to date and to develop, based on these data, a classification of adherence/non-adherence of patients to treatment. The search for literary sources was carried out by keywords. The analysis included publications for the last 20 years — 2003-2023. The categories of adherence were selected for the classification, relevant from the point of view of the general medical approach to the problem, the assessment of which is possible in real clinical practice. All types of adherence were grouped according to the leading feature. The developed classification of adherence/non-adherence of patients to treatment can serve as an additional tool for assessing adherence, which in the future may be useful in choosing strategy and possible ways to increase patients’ adherence to medical recommendations.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>классификация</kwd><kwd>приверженность</kwd><kwd>неприверженность</kwd><kwd>пациенты</kwd><kwd>лечение</kwd><kwd>врачебные рекомендации</kwd></kwd-group><kwd-group xml:lang="en"><kwd>classification</kwd><kwd>adherence</kwd><kwd>non-adherence</kwd><kwd>patients</kwd><kwd>treat­ment</kwd><kwd>medical recommendations</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO Library Cataloguing-in-Publication Data, 2003:5-169. ISBN: 9241545992.</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO Library Cataloguing-in-Publication Data, 2003:5-169. ISBN: 9241545992.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cutler RL, Fernandez-Llimos F, Frommer M, et al. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8:e016982. doi:10.1136/bmjopen-2017-016982.</mixed-citation><mixed-citation xml:lang="en">Cutler RL, Fernandez-Llimos F, Frommer M, et al. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8:e016982. doi:10.1136/bmjopen-2017-016982.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Vrijens B, De Geest S, Hughes DA, et al. ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705. doi:10.1111/j.1365-2125.2012.04167.x.</mixed-citation><mixed-citation xml:lang="en">Vrijens B, De Geest S, Hughes DA, et al. ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691-705. doi:10.1111/j.1365-2125.2012.04167.x.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hugtenburg JG, Timmers L, Elders PJ, et al. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013;7:675-82. doi:10.2147/PPA.S29549.</mixed-citation><mixed-citation xml:lang="en">Hugtenburg JG, Timmers L, Elders PJ, et al. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013;7:675-82. doi:10.2147/PPA.S29549.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">van Dulmen S, Sluijs E, van Dijk L, et al. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7:55. doi:10.1186/1472-6963-7-55.</mixed-citation><mixed-citation xml:lang="en">van Dulmen S, Sluijs E, van Dijk L, et al. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7:55. doi:10.1186/1472-6963-7-55.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155-9. doi:10.5001/omj.2011.38.</mixed-citation><mixed-citation xml:lang="en">Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155-9. doi:10.5001/omj.2011.38.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Лукина Ю. В., Кутишенко Н. П., Марцевич С. Ю. и др. Разработка и валидизация новых опросников в медицине на примере шкалы приверженности к лекарственной терапии. Рациональная Фармакотерапия в Кардиологии. 2020;17(4):576-83. doi:10.20996/1819-6446-2021-08-02.</mixed-citation><mixed-citation xml:lang="en">Lukina YV, Kutishenko NP, Martsevich SY, et al. The Questionnaire Survey Method in Medicine on the Example of Treatment Adherence Scales. Rational Pharmacotherapy in Cardiology. 2020;17(4):576-83. (In Russ.) doi:10.20996/1819-6446-2021-08-02.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Svarstad BL, Chewning BA, Sleath BL, et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113-24. doi:10.1016/s0738-3991(98)00107-4.</mixed-citation><mixed-citation xml:lang="en">Svarstad BL, Chewning BA, Sleath BL, et al. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37(2):113-24. doi:10.1016/s0738-3991(98)00107-4.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hanus JS, Simões PW, Amboni G, et al. Association bet­ween quality of life and medication adherence in hyper­tensive individuals. Acta Paul Enferm. 2015;28(4):381-7. doi:10.1590/1982-0194201500064.</mixed-citation><mixed-citation xml:lang="en">Hanus JS, Simões PW, Amboni G, et al. Association bet­ween quality of life and medication adherence in hyper­tensive individuals. Acta Paul Enferm. 2015;28(4):381-7. doi:10.1590/1982-0194201500064.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lam WY, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/217047.</mixed-citation><mixed-citation xml:lang="en">Lam WY, Fresco P. Medication Adherence Measures: An Overview. Biomed Res Int. 2015;2015:217047. doi:10.1155/2015/217047.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of self-reported measure of medical adherence. Med Care. 1986;24:67-73. doi:10.1097/00005650-198601000-00007.</mixed-citation><mixed-citation xml:lang="en">Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of self-reported measure of medical adherence. Med Care. 1986;24:67-73. doi:10.1097/00005650-198601000-00007.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54. doi:10.1111/j.1751-7176.2008.07572.x.</mixed-citation><mixed-citation xml:lang="en">Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348-54. doi:10.1111/j.1751-7176.2008.07572.x.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Фофанова Т. В., Агеев Ф. Т., Смирнова М. Д. Отечественный опросник приверженности терапии: апробация и применение в амбулаторной практике. Системные гипертензии. 2014;2:13-6.</mixed-citation><mixed-citation xml:lang="en">Fofanova TV, Ageev FT, Smirnova MD. Domestic questionnaire of adherence to therapy: testing and application in outpatient practice. Systemic hypertension. 2014;2:13-6. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Николаев Н. А., Скирденко Ю. П., Жеребилов В. В. Количественная оценка приверженности к лечению в клинической медицине: протокол, процедура, интерпретация. Качественная клиническая практика. 2016;1:50-9.</mixed-citation><mixed-citation xml:lang="en">Nikolaev NA, Skirdenko YP, Zherebilov VV. Quantitative assessment of treatment adherence in clinical medicine: Protocol, procedure, interpretation. Quality clinical practice. 2016;1:50-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sidorkiewicz S, Tran V, Cousyn C, et al. Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient. BMJ Open. 2016;6:e010510. doi:10.1136/bmjopen-2015-010510.</mixed-citation><mixed-citation xml:lang="en">Sidorkiewicz S, Tran V, Cousyn C, et al. Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient. BMJ Open. 2016;6:e010510. doi:10.1136/bmjopen-2015-010510.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med. 2018;169(1):30-5. doi:10.7326/M18-0543.</mixed-citation><mixed-citation xml:lang="en">De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP Medication Adherence Reporting Guideline (EMERGE). Ann Intern Med. 2018;169(1):30-5. doi:10.7326/M18-0543.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Garner JB. Problems of nonadherence in cardiology and proposals to improve outcomes. Am J Cardiol. 2010;105:1495-501. doi:10.1016/j.amjcard.2009.12.077.</mixed-citation><mixed-citation xml:lang="en">Garner JB. Problems of nonadherence in cardiology and proposals to improve outcomes. Am J Cardiol. 2010;105:1495-501. doi:10.1016/j.amjcard.2009.12.077.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rodriguez-Bernal CL, Peiró S, Hurtado I, et al. Primary Nonad­herence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort. J Manag Care Spec Pharm. 2018;24(5):440-8. doi:10.18553/jmcp.2018.24.5.440.</mixed-citation><mixed-citation xml:lang="en">Rodriguez-Bernal CL, Peiró S, Hurtado I, et al. Primary Nonad­herence to Oral Anticoagulants in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort. J Manag Care Spec Pharm. 2018;24(5):440-8. doi:10.18553/jmcp.2018.24.5.440.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">García-Sempere A, Hurtado I, Sanfélix-Genovés C, et al. Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study. Nature. Scientific Reports. 2017,7:11784. doi:10.1038/s41598-017-10899-6.</mixed-citation><mixed-citation xml:lang="en">García-Sempere A, Hurtado I, Sanfélix-Genovés C, et al. Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study. Nature. Scientific Reports. 2017,7:11784. doi:10.1038/s41598-017-10899-6.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Марцевич С. Ю., Лукина Ю. В., Кутишенко Н. П., и др. Приверженность к приему новых оральных антикоагулянтов у пациентов с фибрилляцией предсердий в реальной клинической практике (результаты исследования АНТЕЙ). Рациональная Фармакотерапия в Кардиологии. 2019;15(6):864-72. doi:10.20996/1819-6446-2019-15-6-864-872.</mixed-citation><mixed-citation xml:lang="en">Martsevich SY, Lukina YV, Kutishenko NP, et al. Adherence to treatment with new oral anticoagulants in atrial fibrillation patients in real clinical practice (results of the ANTEY study). Rational Pharmacotherapy in Cardiology. 2019;15(6):864-72. (In Russ.) doi:10.20996/1819-6446-2019-15-6-864-872.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res. 2012;12:98. doi:10.1186/1472-6963-12-98.</mixed-citation><mixed-citation xml:lang="en">Gadkari AS, McHorney CA. Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res. 2012;12:98. doi:10.1186/1472-6963-12-98.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Bae SG, Kam S, Park KS, et al. Factors related to intentional and unintentional medication nonadherence in elderly patients with hypertension in rural community. Patient Prefer Adherence. 2016;10:1979-89. doi:10.2147/PPA.S114529.</mixed-citation><mixed-citation xml:lang="en">Bae SG, Kam S, Park KS, et al. Factors related to intentional and unintentional medication nonadherence in elderly patients with hypertension in rural community. Patient Prefer Adherence. 2016;10:1979-89. doi:10.2147/PPA.S114529.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Лукина Ю. В., Кутишенко Н. П., Марцевич С. Ю. и др. Методические рекомендации "При­верженность к лекарственной терапии у больных хроническими неинфекционными заболеваниями. Решение проблемы в ряде клинических ситуаций". Профилактическая медицина. 2020;23(3):2042-60. doi:10.17116/profmed20202303242.</mixed-citation><mixed-citation xml:lang="en">Lukina IuV, Kutishenko NP, Martsevich SIu, et al. Methodological recommendations: "Adherence to drug therapy in patients with chronic non-communicable diseases. Addressing the problem in a number of clinical situations". Profilakticheskaya Meditsina. 2020;23(3):2042-60. (In Russ.)doi:10.17116/profmed20202303242.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Зырянов С. К., Фитилев С. Б., Возжаев А. В. и др. Приверженность к фармакотерапии у пожилых пациентов с ишемической бо­лезнью сердца в условиях первичного амбулаторного звена. Рациональная Фармакотерапия в Кардиологии. 2021;17(2): 178-85. doi:10.20996/1819-6446-2021-03-03.</mixed-citation><mixed-citation xml:lang="en">Zyryanov SK, Fitilev SB, Vozzhaev AV, et al. Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care. Rational Pharmacotherapy in Cardiology. 2021;17(2):178-85. (In Russ.) doi:10.20996/1819-6446-2021-03-03.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Наумова Е. А., Семенова О. Н. Современный взгляд на проблему приверженности пациентов к длительному лечению. Кардиология: новости, мнения, обучение. 2016;2:30-9.</mixed-citation><mixed-citation xml:lang="en">Naumova EA, Semenova ON. Modern view on the problem of patients’ adherence to long-term treatment. Cardiology: news, opinions, training. 2016;2:30-9. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Wroe AL. Intentional and Unintentional Nonadherence: A Study of Decision Making. J Behav Med. 2002;25:355-72. doi:10.1023/A:1015866415552.</mixed-citation><mixed-citation xml:lang="en">Wroe AL. Intentional and Unintentional Nonadherence: A Study of Decision Making. J Behav Med. 2002;25:355-72. doi:10.1023/A:1015866415552.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and inten­tio­nal nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64(1):41-6. doi:10.1016/j.jpsychores.2007.05.004.</mixed-citation><mixed-citation xml:lang="en">Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and inten­tio­nal nonadherers: application of the Necessity-Concerns Framework. J Psychosom Res. 2008;64(1):41-6. doi:10.1016/j.jpsychores.2007.05.004.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">National Collaborating Centre for Primary Care (UK). Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence [Internet]. London: Royal College of General Practitioners (UK); 2009 Jan. (NICE Clinical Guidelines, No. 76.) https://www.ncbi.nlm.nih.gov/books/NBK55440/. (05 May 2023).</mixed-citation><mixed-citation xml:lang="en">National Collaborating Centre for Primary Care (UK). Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence [Internet]. London: Royal College of General Practitioners (UK); 2009 Jan. (NICE Clinical Guidelines, No. 76.) https://www.ncbi.nlm.nih.gov/books/NBK55440/. (05 May 2023).</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Марцевич С. Ю., Навасардян А. Р., Кутишенко Н. П. и др. Оценка приверженности к приему новых пероральных антикоагулянтов у пациентов с фибрилляцией предсердий по данным регистра ПРОФИЛЬ. Рациональная Фармакотерапия в Кардиологии. 2014;10(6):625-30. doi:10.20996/1819-6446-2014-10-6-625-630.</mixed-citation><mixed-citation xml:lang="en">Martsevich SY, Navasardyan AR, Kutishenko NP, et al. The assessment of compliance to the use of new oral anticoagulants in patients with atrial fibrillation according to the PROFILE register. Rational Pharmacotherapy in Cardiology. 2014;10(6):625-30. (In Russ.) doi:10.20996/1819-6446-2014-10-6-625-630.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Марцевич С. Ю., Лукина Ю. В., Кутишенко Н. П. и др. Приверженность к лечению и качество жизни больных стабильной ишемической болезнью сердца при лечении никорандилом: взаимосвязь и взаимовлияние (по результатам наблюдательного исследования НИКЕЯ). Рациональная Фармакотерапия в Кардиологии. 2018;14(3):409-17. doi:10.20996/1819-6446-2018-14-3-409-417.</mixed-citation><mixed-citation xml:lang="en">Martsevich SY, Lukina YV, Kutishenko NP, et al. Treatment Adherence and Quality of Life of Patients with Stable Ischemic Heart Disease in Treatment with Nicorandil: Interrelation and Interaction (According to the Results of the Observational Study NIKEA). Rational Pharmacotherapy in Cardiology 2018;14(3):409-17. (In Russ.) doi:10.20996/1819-6446-2018-14-3-409-417.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Марцевич С. Ю., Лукина Ю. В., Кутишенко Н. П. и др. Приверженность к терапии статинами пациентов высокого и очень высокого сердечно-сосудистого риска в условиях реальной клинической практики: диагностика и возможные пути решения проблемы (по данным наблюдательного исследования ПРИОРИТЕТ). Рациональная Фармакотерапия в Кардиологии. 2018;14(6):891-900. doi:10.20996/1819-6446-2018-14-6-891-900.</mixed-citation><mixed-citation xml:lang="en">Martsevich SYu, Lukina YuV, Kutishenko NP, et al. Adherence to Statins Therapy of High and Very High Cardiovascular Risk Patients in Real Clinical Practice: Diagnostics and Possible Ways to Solve the Problem (According to the PRIORITY Observational Study). Rational Pharmacotherapy in Cardiology. 2018;14(6):891-900. (In Russ.) doi:10.20996/1819-6446-2018-14-6-891-900.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Unni E, Farris KB. Determinants of different types of medication non-adherence in cholesterol lowering and asthma maintenance medications: a theoretical approach. Patient Educ Couns. 2011;83(3):382-90. doi:10.1016/j.pec.2011.02.017.</mixed-citation><mixed-citation xml:lang="en">Unni E, Farris KB. Determinants of different types of medication non-adherence in cholesterol lowering and asthma maintenance medications: a theoretical approach. Patient Educ Couns. 2011;83(3):382-90. doi:10.1016/j.pec.2011.02.017.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Gast A, Mathes T. Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst Rev. 2019;10;8(1):112. doi:10.1186/s13643-019-1014-8.</mixed-citation><mixed-citation xml:lang="en">Gast A, Mathes T. Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst Rev. 2019;10;8(1):112. doi:10.1186/s13643-019-1014-8.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Кадыров Р. В., Асриян О. Б., Ковальчук С. А. Опросник "Уровень комплаентности". Владивосток: Мор. гос. ун-т, 2014. p.74. ISBN: 978-5-8343-0927-7.</mixed-citation><mixed-citation xml:lang="en">Kadyrov RV, Asriyan OB, Kovalchuk SA. The questionnaire "Compliance level". Vladivostok: Moscow State University, 2014. p. 74. (In Russ.) ISBN: 978-5-8343-0927-7.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. doi:10.1136/bmj.38875.675486.55.</mixed-citation><mixed-citation xml:lang="en">Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. doi:10.1136/bmj.38875.675486.55.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Марцевич С. Ю., Толпыгина С. Н., Чернышева М. И. и др. Приверженность посещению поликлиники и отдаленная выживаемость больных, перенесших острое нарушение мозгового кровообращения, по данным амбулаторного этапа наблюдения в регистре РЕГИОН-М (посещение поликлиники и выживаемость после инсульта). Рациональная Фармакотерапия в Кардиологии 2021;17(3):386-93. doi:10.20996/1819-6446-2021-06-04.</mixed-citation><mixed-citation xml:lang="en">Martsevich SY, Tolpygina SN, Chernysheva MI, et al. Adherence to Attendance at Outpatient Clinic and Longterm Survival of Patients after Stroke in Outpatient Setting: the Data of REGION-M Registry. Rational Pharmacotherapy in Cardiology 2021;17(3):386-93. (In Russ.) doi:10.20996/1819-6446-2021-06-04.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Martsevich SY, Semenova YV, Kutishenko NP, et al. Assessment of patients’ attendance at outpatient clinics and prehospital therapy: Russian acute coronary syndrome registry LISS-3 data. Indian Heart J. 2017;69(1):105-6. doi:10.1016/j.ihj.2016.11.005.</mixed-citation><mixed-citation xml:lang="en">Martsevich SY, Semenova YV, Kutishenko NP, et al. Assessment of patients’ attendance at outpatient clinics and prehospital therapy: Russian acute coronary syndrome registry LISS-3 data. Indian Heart J. 2017;69(1):105-6. doi:10.1016/j.ihj.2016.11.005.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509-10.</mixed-citation><mixed-citation xml:lang="en">Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509-10.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Podsadecki TJ, Vrijens BC, Tousset EP, et al. "White Coat Compliance" Limits the Reliability of Therapeutic Drug Monitoring in HIV-1–Infected Patients. HIV Clinical Trials. 2008;9:4:238-46. doi:10.1310/hct0904-238.</mixed-citation><mixed-citation xml:lang="en">Podsadecki TJ, Vrijens BC, Tousset EP, et al. "White Coat Compliance" Limits the Reliability of Therapeutic Drug Monitoring in HIV-1–Infected Patients. HIV Clinical Trials. 2008;9:4:238-46. doi:10.1310/hct0904-238.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Driscoll KA, Wang Y, Johnson SB, et al. White Coat Adherence Occurs in Adolescents With Type 1 Diabetes Receiving Intervention to Improve Insulin Pump Adherence Behaviors. Journal of Diabetes Science and Technology. 2017;11(3):455-60. doi:10.1177/1932296816672691.</mixed-citation><mixed-citation xml:lang="en">Driscoll KA, Wang Y, Johnson SB, et al. White Coat Adherence Occurs in Adolescents With Type 1 Diabetes Receiving Intervention to Improve Insulin Pump Adherence Behaviors. Journal of Diabetes Science and Technology. 2017;11(3):455-60. doi:10.1177/1932296816672691.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Zueger T, Gloor M, Lehmann V, et al. White coat adherence effect on glucose control in adult individuals with diabetes. Diabetes Res Clin Pract. 2020;168:108392. doi:10.1016/j.diabres.2020.108392.</mixed-citation><mixed-citation xml:lang="en">Zueger T, Gloor M, Lehmann V, et al. White coat adherence effect on glucose control in adult individuals with diabetes. Diabetes Res Clin Pract. 2020;168:108392. doi:10.1016/j.diabres.2020.108392.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Baumgartner PC, Haynes RB, Hersberger KE, et al. A Systematic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes. Front Pharmacol. 2018;9:1290. doi:10.3389/fphar.2018.01290.</mixed-citation><mixed-citation xml:lang="en">Baumgartner PC, Haynes RB, Hersberger KE, et al. A Systematic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes. Front Pharmacol. 2018;9:1290. doi:10.3389/fphar.2018.01290.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc. 2011;51(1):90-4. doi:10.1331/JAPhA.2011.09154.</mixed-citation><mixed-citation xml:lang="en">Lavsa SM, Holzworth A, Ansani NT. Selection of a validated scale for measuring medication adherence. J Am Pharm Assoc. 2011;51(1):90-4. doi:10.1331/JAPhA.2011.09154.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Лукина Ю. В., Кутишенко Н. П., Марцевич С. Ю. и др. Опросники и шкалы для оценки приверженности к лечению — преимущества и недостатки диагностического метода в научных исследованиях и реальной клинической практике. Кардиоваскулярная терапия и профилактика. 2020;19(3):2562. doi:10.15829/1728-8800-2020-2562.</mixed-citation><mixed-citation xml:lang="en">Lukina YuV, Kutishenko NP, Martsevich SYu, et al. Questionnaires and scores for assessing medication adherence — advantages and disadvantages of the diagnostic method in research and actual clinical practice. Cardiovascular Therapy and Prevention. 2020;19(3):2562. (In Russ.) doi:10.15829/1728-8800-2020-2562.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Фитилёв С. Б., Возжаев А. В., Шкребнева И. И. и др. Приверженность фармакотерапии сердечно-сосудистых заболеваний: современное состояние вопроса. Качественная клиническая практика. 2019;4:66-80. doi:10.1016/2588-0519-2019-4-66-80.</mixed-citation><mixed-citation xml:lang="en">Fitilev SB, Vozzhaev AV, Shkrebneva II, et al. Adherence to pharmacotherapy of cardiovascular diseases: the current state of the issue. High-quality clinical practice. 2019;4:66-80. (In Russ.) doi:10.1016/2588-0519-2019-4-66-80.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
